Eagle Pharmaceuticals, Inc.

VANGUARD GROUP INC EGRX

Report date

9/30/2024

Quarter

2024 Q3

Filed

11/13/2024

Shares

579,507

Value ($000)

2,162

Weight

0.0%

2014 Q2 - 2024 Q3 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q3	11/13/2024	2,162	0.0%	579,507	9/30/2024
2024 Q2	8/13/2024	3,161	0.0%	564,396	6/30/2024
2024 Q1	5/10/2024	3,358	0.0%	640,754	3/31/2024
2023 Q4	3/11/2024	3,337	0.0%	638,124	12/31/2023
2023 Q3	12/18/2023	10,150	0.0%	643,597	9/30/2023
2023 Q2	8/14/2023	12,086	0.0%	621,686	6/30/2023
2023 Q1	7/14/2023	21,468	0.0%	756,732	3/31/2023
2022 Q4	2/10/2023	22,326	0.0%	763,807	12/31/2022
2022 Q3	11/14/2022	20,488	0.0%	775,515	9/30/2022
2022 Q2	8/12/2022	34,288	0.0%	771,759	6/30/2022
2022 Q1	5/13/2022	38,644	0.0%	780,851	3/31/2022
2021 Q4	2/14/2022	38,724	0.0%	760,468	12/31/2021
2021 Q3	11/12/2021	42,564	0.0%	763,066	9/30/2021
2021 Q2	8/13/2021	32,240	0.0%	753,280	6/30/2021
2021 Q1	5/14/2021	32,267	0.0%	773,067	3/31/2021
2020 Q4	2/12/2021	35,622	0.0%	764,935	12/31/2020
2020 Q3	11/16/2020	31,389	0.0%	738,909	9/30/2020
2020 Q2	8/14/2020	35,167	0.0%	732,944	6/30/2020
2020 Q1	5/15/2020	34,032	0.0%	739,802	3/31/2020
2019 Q4	2/14/2020	45,683	0.0%	760,370	12/31/2019
2014 Q2	8/11/2014	176	0.0%	12,252	6/30/2014